Skip to main content
Livermore
Livermore
ZHEN

Intelligent Bio Solutions Inc.

INBS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001725430

No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.

Holders of 5% or more of INBS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Intelligent Bio Solutions Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of INBS
HolderLatest formStakeChangeFirst filedLatest filingFiling
Alyeska Investment Group, L.P.13G/A9.99%944.3K shares–Nov 14, 20251 filingNov 14, 2025SEC
Armistice Capital, LLC13G/A5.91%141.4K shares−4.08 ppfrom 9.99%May 15, 20262 filingsAug 14, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Intelligent Bio Solutions Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on INBS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 202610:17 AM ETArmistice Capital, LLCand 1 other13G/A5.91%141.4K shares−4.08 ppfrom 9.99%Jun 30, 2026SEC
May 15, 202611:24 AM ETArmistice Capital, LLCand 1 other13G9.99%163.6K sharesNewMar 31, 2026SEC
Nov 14, 20258:00 PM ETAlyeska Investment Group, L.P.and 2 others13G/A9.99%944.3K shares–Sep 30, 2025SEC
Feb 4, 20259:14 AM ETBigger Capital Fund L Pand 6 others13G/A4.99%303.0K shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Intelligent Bio Solutions Inc. shares.

No Form 144 notices for Intelligent Bio Solutions Inc. are on file.